skip to Main Content
Interoperability

We promote the exchange and the use of biological samples

Once the sample-related data from different biobanks are comparable and searchable, researchers can assess the samples suitability for their projects. 

Interoperability strategy

Relevant sample data needs to be documented in a standardized way to become comparable and searchable. Biobanks are under ever growing pressure to improve documentation of samples and processes.  

What are our means of facilitating Interoperability?

SBP currently makes available several datasets that will soon be revised and integrated in a new Biobank Information Management System (BIMS) to provide an adaptive and interoperable solution to biobanks. 

Follow the developments
Read our related newsletters

« Finally a sample life cycle management tool (BIMS) that will be flexible, intuitive, promote standards and affordable to answer all your research needs. A great way to speed up discoveries! »

Raphaël Colsenet — IT Solution Architect, SBP Consultant

Datasets

5 datasets exist for tissue and liquid samples derived from human and animals.

National experts who took part to SBP Working Groups agreed upon a list of data required to be documented for each sample.  

From these, a selected number of data (mandatory and relevant for sharing) has been chosen to create the SBP sharing minimal dataset used in NExT. 

New developments

SBP is reviewing the v1.0 version of the datasets and defining the minimum requirements in terms of documentation. 

This revision of 2022 will involve national biobanking experts and aims at being aligned with SPHN current activities around interoperability and harmonization of cDWHs among university hospitals. 

 

BIMS

Engage in the development of an adaptive solution that will facilitate traceability and interoperability.

Thanks to our large network of biobanks, we are in the unique situation of understanding the various needs of biobanks of all sizes and scopes in Switzerland .

SBP aims to build a new BIMS that would address regular shortcomings for the use of Swiss biobanks. Our goal is to establish a dynamic study design tool that enables a precise and meaningful representation of any given study protocol in the BIMS data flow.  

More news to come

Back To Top

Join our mailing list

Stay updated with our monthly newsletter